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Inflammation is a normal reaction of an organism on
infection or injury. Being a multistep and tightly regulated
process, inflammation involves various cells of innate and
adaptive immune systems. Macrophages are the key cells
of innate immunity responsible for initiation, control and
downregulation of inflammation. Malfunction of macro-
phages is responsible for the development of periodontitis
and their exaggerated reaction plays an important role in
the onset and severity of the peri-implant diseases. Activa-
tion of macrophages may be achieved by microbial pro-
ducts or inflammatory cytokines including IFNgamma
thereby leading to the development of type 1 phenotype
(M1). On the other hand, anti-inflammatory cytokines or
Th2-cells-associated cytokines such as IL-4 induce type 2
macrophages (M2). While M1 are responsible for inflam-
mation initiation and amplification, M2 are needed to
reduce inflammatory activity and to initiate tissue repair
and healing. The balance between type 1 and type 2 acti-
vation has to be strongly maintained to prevent develop-
ment of chronic inflammation or fibrosis. It is in the
nature of human population heterogeneity that in immune
system of some patients type 1 or type 2 reaction prevails.
This individual property has a genetic background and
may lead to unexpected complications of the treatment.
Our research on macrophage biology enabled us to
develop a cell-based system that can be used both as a
diagnostic tool and as a model for development of novel
immunomodulatory therapies capable of reducing compli-
cation during treatment. This cell-based system may be
used for prediction of unwanted reaction of the patient to
the implant material, identification of undesired immune
status of the organism and to design personalized immu-
nomodulatory strategy to improve the outcome of the
treatment. Innovative approaches for modulation of
macrophage reaction to dental implants are developed in
our laboratory.
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